Preparation and evaluation of LA-PEG-SPION, a targeted MRI contrast agent for liver cancer
Open Access
- 15 August 2022
- journal article
- research article
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 17 (1) , 952-959
Abstract
This study aims to synthesize a magnetic resonance imaging (MRI) contrast agent that can specifically target the asialoglycoprotein receptor of liver cancer cells and evaluate its ability as a targeted MRI contrast agent. Lactobionic acid (LA) and polyethylene glycol (PEG) were used to modify superparamagnetic iron oxide nanoparticles (SPION) to obtain LA-PEG-SPION. LA-PEG-SPION was uniformly spherical under the electron microscope, with regular morphology and good dispersion. The particle size of LA-PEG-SPION was about 30 ± 4.5 nm, and its surface potential was about 31 ± 1.5 mV. LA-PEG-SPION had no toxicity or low toxicity to HepG2 cells and HeLa cells, even at 400 μg/mL. The uptake of LA-PEG-SPION by HepG2 cells was higher than that of SPION, with increased blue-stained particles. The fluorescent labeling rate of HepG2 cells reached 68.8%, which was higher than that of the control group. In vitro, MRI showed that the T2-weighted signal intensity of HepG2 cells was lower than that of the control group. Conclusively, LA-PEG-SPION nanoparticles are synthesized in a simple and efficient way. They are successfully applied to the T2-weighted contrast-enhanced MRI in liver cancer in vitro, and they have the potential to be used for in vivo research and clinical studies.Keywords
This publication has 25 references indexed in Scilit:
- Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticlesJournal of Microencapsulation, 2014
- Amine enrichment and poly(ethylene glycol) (PEG) surface modification of thin-film composite forward osmosis membranes for organic fouling controlJournal of Membrane Science, 2014
- Galactosylated manganese ferrite nanoparticles for targeted MR imaging of asialoglycoprotein receptorNanotechnology, 2013
- Expression of Asialoglycoprotein Receptor 1 in Human Hepatocellular CarcinomaJournal of Histochemistry & Cytochemistry, 2013
- Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia TreatmentTheranostics, 2013
- Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeuticsExpert Opinion on Drug Delivery, 2012
- Superparamagnetic Iron Oxide Nanoparticles (SPION) for the Treatment of Antibiotic‐Resistant BiofilmsSmall, 2012
- Antiproliferative Effect of 13-cis-Retinoic Acid is Associated with Granulocyte Differentiation and Decrease in Cyclin B1 and Bcl-2 Protein Levels in G0/G1 Arrested HL-60 CellsPathology and Oncology Research, 2010
- Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R)Bioorganic & Medicinal Chemistry, 2009
- Synthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials, 2005